[Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine].
The authors have studied IgA level in nasal mucus of children, either not treated-controls, or treated with carbocysteine. All had common rhinobronchial diseases. They have noted a significant increase in IgA level in the treated group, from the 7th day.
D002233:Carbocysteine / Q000627:therapeutic use*; D002675:Child, Preschool; D003545:Cysteine / Q000031:analogs & derivatives*; D006801:Humans; D007071:Immunoglobulin A, Secretory / Q000032:analysis*; D007223:Infant; D009297:Nasal Mucosa / Q000276:immunology*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000276:immunology; D013997:Time Factors
D007071:Immunoglobulin A, Secretory; D002233:Carbocysteine; D003545:Cysteine
Modifications du taux des IgA du mucus nasal au décours des affections des voies aériennes supérieures du nourrisson traitées par la carbocistéine.